Malignant pleural mesothelioma: Clinicopathologic and survival characteristic in a consecutive series of 40 patients

Annals of Thoracic and Cardiovascular Surgery

Volumn 17, Issue 2, 2011, Pages 130-136

  Bagheri, Reza ^a,c   Haghi, Seyed Ziaollah ^a   Rahim, Mohammad Bagher ^b   Attaran, Davoud ^a   Toosi, Mehdi Silanian ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diagnosis; Malignant mesthelioma; Pleura; Treatment

Indexed keywords

EID: 79955612875     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: 10.5761/atcs.oa.09.01427     Document Type: Article

References (27)

1. Lopes C, Sotto-Mayor R, Teixeira E, Almeida A. Malignant mesothelioma: A ten years experience. Rev Port Pneumol 2005; 11 (suppl 1): 16-8.
2. Ho L, Sugarbaker DJ, Skarin AT. Malignant pleural mesotheliomas. Cancer Treat Res 2001; 105: 327-73.
3. Neumeister W, Gillissen A, Rasche K, Theile A, Muller KM. Prognosis, staging and therapy of malignant pleural mesothelioma. Med Klin (munich) 2002; 97: 459-71.
4. De Klerk NH, Musk AW. Epidemiology of mesothelioma, In: Robinson BWS, Chahinian PA, eds, Mesothelioma. London: Martin Dunitz, 2002; pp 339-50.
5. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960; 17: 260-71.
6. Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: A clinicopathological correlation of 1445 cases. Ultrastruct Pathol 2002; 26: 55-65.
7. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994; 9: 1781-90.
8. Lee YC, Light RW, Musk AW. Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med 2000; 6: 267-74.
9. Evans AL, Gleeson FV. Radiology in pleural disease: state of the art. Respirology 2004; 9: 300-12.
10. Saad RS, Cho P, Liu YL, Silverman JF. The value of epithelial membrane antigen expression in separating bengin mesothelial proliferation from malignant mesothelioma: a comparative study. Diagn Cytopathol 2005; 32: 156-9.
11. Segal A, Whitaker D, Henderson D, Shilkin K. Pathology of mesothelioma, In: Robinson BWS, Chahinian AP, eds, Mesothelioma. London: Martin Dunitz, 2002; pp 143-84.
12. Canto A, Guijarro R, Arnau A, Galbis J, Martorell M, et al. Videothoracoscopy in the diagnosis and treatment of malignant pleural mesothelioma with associated pleural effusions. Thorac Cardiovasc Surg 1997; 45: 16-9.
13. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976; 31: 15-24.
14. Schipper PH, Nichols FC, Thomse KM, Deschamps C, Cassivi SD, et al. Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg 2008; 85: 257-64; discussion 264.
15. Chamberlain M, Martin H, Fareed K, Nakas A, Antonio E. Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008; 34: 200-3.
16. Sugarbaker DJ, Heher EC, Lee TH, Couper G, Mentzer S, et al. Exterapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1991; 102: 10-5.
17. Okada M, Mimura T, Ohbayashi C, Sakuma T, Soejima T, et al. Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact Cardiovasc Thorac Surg 2008; 7: 102-6.
18. Aigner C, Hoda M, Lang G, Taghavi S, Marta G, et al. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008; 34: 204-7.
19. Phillips PG, Asimakopoulos G, Maiwand MO. Malignant pleural mesothelioma: Outcome of limited surgical management. Interact Cardio Vasc Thorac Surg 2003; 2: 30-24.
20. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, et al. Extrapleural pneumonectomy versus pleurectomy/ decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008; 135: 620-6.
21. Martin-Ucar AE, Nakas A, Edwards JG, Waller DA. Case-control study between extrapleural pneumonectomy and radical pleurectomy/ decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 2007; 31: 765-70.
22. Aelony Y, Yao JF. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series. Respirology 2005; 10: 649-55.
23. Ardizzoni A, Grossi F, Pennucci MC. Systemic drug therapy of malignant pleural mesothelioma. Monaldi Arch Chest Dis 1998; 53: 236-40.
24. Lucchi M, Chella A, Melfi F, Dini P, Ambrogi M, et al. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma. Eur J Cardiothorac Surg 2007; 31: 529-33.
25. Sauter ER, Langer C, Coia LR, Goldberg M, Keller SM. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. J Surg Oncol 1995; 60: 100-5.
26. Mineo TC, Ambrogi V, Pompeo E, Baldi A, Stella F, et al. The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma. Ann Thorac Surg 2008; 85: 1740-6.
27. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, et al. Resection margins, extrapleural nodal status, and cell type determine post operative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999; 117: 54-63.